Johnson & Johnson - Minority Interest Expense
Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Minority-Interest-Expense" stands at 0.083 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2024, the highest value since 09/30/2013.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 22.81 Billion United States Dollars compared to the value the year prior.
The 1 year change is 22.81 Billion United States Dollars.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2023, to it's latest available value, on 09/30/2024, is +22.81 Billion.
The Serie's change in United States Dollars from it's maximum value, on 09/30/2012, to it's latest available value, on 09/30/2024, is -0.256 Billion.
Minority Interest Expense for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Minority Interest Expense | 905,699,262,464.00 |
 | AbbVie Inc - Minority Interest Expense | 399,570,305,024.00 |
 | Roche Holding AG - Minority Interest Expense | 317,433,206,677.55 |
 | AstraZeneca PLC - Minority Interest Expense | 280,205,508,085.11 |
 | Novartis AG - Minority Interest Expense | 255,096,620,580.91 |